Page last updated: 2024-09-05

enzastaurin and B-Cell Chronic Lymphocytic Leukemia

enzastaurin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denk, U; Egle, A; Greil, R; Heyder, C; Hofbauer, S; Holler, C; Piñón, JD1
Bogner, C; Decker, T; Feuerstacke, Y; Lutzny, G; Oelsner, M; Peschel, C; Ringshausen, I; Wagner, M; zum Büschenfelde, CM1
Fournié, JJ; Laurent, G; Liffraud, C; Quillet-Mary, A; Ysebaert, L1

Other Studies

3 other study(ies) available for enzastaurin and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
    Blood, 2009, Mar-19, Volume: 113, Issue:12

    Topics: Aged; Aged, 80 and over; Alleles; Animals; B-Lymphocytes; CD5 Antigens; Cell Line, Tumor; Chromones; Crosses, Genetic; Female; Humans; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Knockout; Mice, Transgenic; Middle Aged; Morpholines; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt

2009
Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
    Leukemia, 2010, Volume: 24, Issue:1

    Topics: Apoptosis; Humans; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Microdomains; Phosphorylation; Proteasome Endopeptidase Complex; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-bcl-2; Receptors, Antigen, B-Cell; Signal Transduction; ZAP-70 Protein-Tyrosine Kinase

2010
Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:5

    Topics: Antineoplastic Agents; Cell Death; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Tumor Cells, Cultured; Vidarabine

2012